Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Other Working Capital Changes (2019 - 2025)

AVITA Medical (RCEL) has disclosed Other Working Capital Changes for 5 consecutive years, with $141212.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Working Capital Changes rose 159.08% year-over-year to $141212.0, compared with a TTM value of $141212.0 through Dec 2025, down 86.2%, and an annual FY2025 reading of $141212.0, down 70.97% over the prior year.
  • Other Working Capital Changes was $141212.0 for Q4 2025 at AVITA Medical, up from -$8000.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $1.9 million in Q1 2024 and bottomed at -$628000.0 in Q3 2023.
  • Average Other Working Capital Changes over 4 years is $41568.2, with a median of -$10500.0 recorded in 2023.
  • The sharpest move saw Other Working Capital Changes tumbled 2065.52% in 2023, then soared 15616.67% in 2024.
  • Year by year, Other Working Capital Changes stood at -$86000.0 in 2022, then tumbled by 341.86% to -$380000.0 in 2023, then skyrocketed by 37.11% to -$239000.0 in 2024, then surged by 159.08% to $141212.0 in 2025.
  • Business Quant data shows Other Working Capital Changes for RCEL at $141212.0 in Q4 2025, -$8000.0 in Q3 2025, and -$9000.0 in Q2 2025.